U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07151456) titled 'Short-term gluCOCOrticoid in Adult STEROID-sensitive Nephrotic Syndrome: The COCO-ASTEROID Study' on Aug. 19.
Brief Summary: This study will compare a short-term course (12 week) glucocorticoid regimen with the Conventional 24-week regimen as originally proposed by KDIGO. The purpose of the study is to determine a short-term course (12 week) of glucocorticoid decreases the time to first relapse in adults presenting with steroid sensitive nephrotic syndrome.
Study Start Date: Jan., 2026
Study Type: INTERVENTIONAL
Condition:
Idiopathic Nephrotic Syndrome
Intervention:
DRUG: Conventional 24-week glucocorticoid regimen
Weeks 1 - ...